Characterisation of severe, steroid-dependent asthma patients who initiate biologics versus those who do not
W. Chen (Vancouver, Canada), M. Sadatsafavi (Vancouver, Canada), L. Bulathsinhala (Singapore, Singapore), E. Garcia Gil (Gaithersburg, United States of America), T. Tran (Gaithersburg, United States of America), J. Fitzgerald (Vancouver, Canada), R. Murray (Singapore, Singapore), D. Price (Singapore, Singapore), I. Glitter Working Group (Singapore, Singapore)
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Chen (Vancouver, Canada), M. Sadatsafavi (Vancouver, Canada), L. Bulathsinhala (Singapore, Singapore), E. Garcia Gil (Gaithersburg, United States of America), T. Tran (Gaithersburg, United States of America), J. Fitzgerald (Vancouver, Canada), R. Murray (Singapore, Singapore), D. Price (Singapore, Singapore), I. Glitter Working Group (Singapore, Singapore). Characterisation of severe, steroid-dependent asthma patients who initiate biologics versus those who do not. 1105
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: